Allied Market Research
Loading...
0
New
New
2021
Veterinary Artificial Reproduction Market

Veterinary Artificial Reproduction Market by Product (Equipment, Reagents & Kits, and Others), Technique (Artificial Insemination, In-Vitro Fertilization (IVF) Technology and Others), and End User (Veterinary Hospitals, Veterinary Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A13676
Pages: 169
Sep 2021 | 156 Views
   
Author(s) : Apoorva Srivastava , Onkar Sumant
Tables: 86
Charts: 18
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Veterinary Artificial Reproduction Market

Request Now !

The global veterinary artificial reproduction market was valued at $1,349.4 million in 2020, and is estimated to reach $2,229.3 million by 2030, growing at a CAGR of 5.30% from 2021 to 2030.

The COVID-19 cases are because of direct or indirect contact between humans. There has been no evidence or confirmation that animals can spread COVID-19 to humans. Furthermore, COVID-19 has weakened the supply chain and has created shortage of animal health products such as nutritional feed as well as vaccines globally.

Veterinary artificial reproduction is used to breed cattle and other livestock using frozen semen. Artificial reproduction has to be carried out at the right time during the animal’s heat cycle to attain best results. Previously, livestock had to be monitored for heat to breed them at the appropriate time. In recent years, synchronization protocols are being implemented to bring majority of herd into heat cycles so that they can all be bred at the same time. In addition, advancements in synchronization of heat cycles among herds have made artificial reproduction more feasible. Furthermore, artificial reproduction reduces risks involved with animal breeding and disease transmission, which has increased demand for artificial reproduction in animal husbandries. Artificial reproduction allows herders to breed livestock with superior genes. In cattle herding, artificial reproduction can result in female offsprings that have greater capabilities of milk production. By using semen from sires that have high fertility rates, herders can improve conception rates and produce more calves, and can predict qualities of calves to a certain extent.

Veterinary-Artificial-Reproduction-Market,-2021-2030

Get more information on this report : Request Sample Pages

Artificial reproduction results in reduction of calving difficulties and weans larger calves that have better and more desirable carcasses. Artificial reproduction can increase profits of herders and have proved to be more efficient than natural breeding. Artificial reproduction process uses semen extenders that have antibiotics in them that prevents spread of bacterial diseases. Furthermore, artificial reproduction is considered to be more hygienic than natural breeding, which also contributes toward reduced spread of diseases.

Needs of farmers and production requirements change as the market changes. These changes often result in certain animal breeds unfeasible to raise. Artificial reproduction allows farmers to continue to farm these breeds in-situ. There have been no studies demonstrating that novel coronavirus can propagate among livestock. However, pandemic-induced lockdowns have affected supply chains and have resulted in a lack of veterinary products such as nutritional feed.

Governments across the globe have undertaken initiatives to support animal husbandries by providing them with telephonic assistance and delivering artificial insemination services to their doorstep. Growth in demand for animal products mainly due to growth in human population has also increased demand for artificial insemination as farmers try to meet growing demands. Artificial reproduction has also effectively reduced prices of bulls. Artificial insemination is also lucrative for farmers as calf prices are increasing and have contributed to growth of the veterinary artificial reproduction market. It allows breeders to breed genetically superior offsprings with desirable traits.

Animals cannot propagate COVID-19 to humans, according to the COVID-19 pandemic. The global supply chain has been disrupted by coronavirus pandemic, resulting in a lack of animal health items such as organic feed. As a result, it may be made up of animal feed, affecting reproductive ability.

veterinary artificial reproduction market segmentation

The veterinary artificial reproduction market is segmented on the basis of product, technique, end user, and region. By product, the market is categorized into equipment, reagents & kits, and others. By technique, the market is divided into artificial insemination, in-vitro fertilization (IVF) technology, and others. By end user, it is fragmented into veterinary hospitals, veterinary clinics, and others.

Veterinary Artificial Reproduction Market
By Product

Your browser does not support the canvas element.

Reagents and Kits segment holds the dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Veterinary Artificial Reproduction Market
By Technique

Your browser does not support the canvas element.

Artificial Insemination segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Segment review

Depending on product, the reagent & kits segment dominated the market in 2020, and is expected to continue this trend throughout the forecast period. This is attributed to growing infectious diseases in animals and rise in awareness about artificial insemination among people. On the basis of technique, the artificial insemination segment dominated the market in 2020, and is expected to continue this trend throughout the forecast period. This is attributed to increase consumption of animal protein and growth in demand for high cattle productivity & milk yield.

Veterinary Artificial Reproduction Market
By End User

Your browser does not support the canvas element.

Veterinary Hospitals segment holds the dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Europe accounted for a major share in the veterinary artificial reproduction market in 2020, and is expected to maintain its dominance during the forecast period, owing to rise in healthcare awareness, coupled with growth in demand for fishery and animal husbandry products, which is expected to drive the veterinary artificial reproduction market during the forecast period. Moreover, presence of major players operating in the region fuel growth of the market. However, Asia-pacific is expected to register highest CAGR from 2021 to 2030, owing to presence of a large livestock population in this region. Increase in demand for milk and animal-based protein, along with government initiatives propel the market growth. Furthermore, innovations and developments toward artificial reproduction are anticipated to further enhance growth in this region in the future.

Veterinary Artificial Reproduction Market
By Region

2030
Europe 
North America
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 6.90% during 2021-2030

Get more information on this report : Request Sample Pages

The key players operating in the global market include Bovine Elite LLC, KRUUSE, Agtech Inc., IMV Technologies, Zoetis Inc., Neogen Corporation, National Meditek, Swine Genetics International, and Select Sires Inc., SEMEX.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global veterinary artificial reproduction market, and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Key Market Segments

By Product

  • Equipment
  • Reagents and Kits
  • Others

By Technique

  • Artificial Insemination
  • In- Vitro Fertilization (IVF) Technology
  • Others

By End User

  • Veterinary Hospitals
  • Veterinary Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players

  • Bovine Elite LLC
  • KRUUSE
  • Agtech Inc.
  • IMV Technologies
  • Zoetis Inc.
  • Neogen Corporation
  • National Meditek
  • Swine Genetics International
  • Select Sires Inc.
  • SEMEX
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.3.1.Top player positioning

3.4.Market dynamics

3.4.1.Drivers, restraints, and opportunity
3.4.2.Drivers

3.4.2.1.Increase in adoption veterinary artificial insemination (AI)

3.4.3.Restraint

3.4.3.1.Semen contamination restraint the market growth

3.4.4.Opportunities

3.4.4.1.Government support affecting animal health services influencing market growth

3.5.Impact of COVID-19 on the veterinary artificial reproduction market

CHAPTER 4:VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Equipment

4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Reagents and Kits

4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Others

4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE

5.1.Overview

5.1.1.Market size and forecast

5.2.Artificial Insemination

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.2.2.1.Market size and forecast, by end user

5.3.In- Vitro Fertilization (IVF) Technology

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.3.2.1.Market size and forecast, by end user

5.4.Others

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.4.2.1.Market size and forecast, by end user

CHAPTER 6:VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Veterinary Hospitals

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Veterinary Clinics

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Others

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key opportunities and forecast
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by product
7.2.4.Market size and forecast, by technique
7.2.5.Market size and forecast, by end user

7.2.5.1.U.S.

7.2.5.1.1.U.S. market size and forecast, by product
7.2.5.1.2.U.S. market size and forecast, by technique
7.2.5.1.3.U.S. market size and forecast, by end user

7.2.5.2.Canada

7.2.5.2.1.Canada market size and forecast, by product
7.2.5.2.2.Canada market size and forecast, by technique
7.2.5.2.3.Canada market size and forecast, by end user

7.2.5.3.Mexico

7.2.5.3.1.Mexico market size and forecast, by product
7.2.5.3.2.Mexico market size and forecast, by technique
7.2.5.3.3.Mexico market size and forecast, by end user

7.3.Europe

7.3.1.Key opportunities and forecast
7.3.2.Market size and forecast, by country
7.3.3.Market size and forecast, by product
7.3.4.Market size and forecast, by technique
7.3.5.Market size and forecast, by end user

7.3.5.1.Germany

7.3.5.1.1.Germany market size and forecast, by product
7.3.5.1.2.Germany market size and forecast, by technique
7.3.5.1.3.Germany market size and forecast, by end user

7.3.5.2.France

7.3.5.2.1.France market size and forecast, by product
7.3.5.2.2.France market size and forecast, by technique
7.3.5.2.3.France market size and forecast, by end user

7.3.5.3.UK

7.3.5.3.1.UK market size and forecast, by product
7.3.5.3.2.UK market size and forecast, by technique
7.3.5.3.3.UK market size and forecast, by end user

7.3.5.4.Italy

7.3.5.4.1.Italy market size and forecast, by product
7.3.5.4.2.Italy market size and forecast, by technique
7.3.5.4.3.Italy market size and forecast, by end user

7.3.5.5.Spain

7.3.5.5.1.Spain market size and forecast, by product
7.3.5.5.2.Spain market size and forecast, by technique
7.3.5.5.3.Spain market size and forecast, by technique

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe market size and forecast, by product
7.3.5.6.2.Rest of Europe market size and forecast, by technique
7.3.5.6.3.Rest of Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key opportunities and forecast
7.4.2.Market size and forecast, by country
7.4.3.Market size and forecast, by product
7.4.4.Market size and forecast, by technique
7.4.5.Market size and forecast, by end user

7.4.5.1.Japan

7.4.5.1.1.Japan market size and forecast, by product
7.4.5.1.2.Japan market size and forecast, by technique
7.4.5.1.3.Japan market size and forecast, by end user

7.4.5.2.China

7.4.5.2.1.China market size and forecast, by product
7.4.5.2.2.China market size and forecast, by technique
7.4.5.2.3.China market size and forecast, by end user

7.4.5.3.Australia

7.4.5.3.1.Australia market size and forecast, by product
7.4.5.3.2.Australia market size and forecast, by technique
7.4.5.3.3.Australia market size and forecast, by end user

7.4.5.4.India

7.4.5.4.1.India market size and forecast, by product
7.4.5.4.2.India market size and forecast, by technique
7.4.5.4.3.India market size and forecast, by technique

7.4.5.5.South Korea

7.4.5.5.1.South Korea market size and forecast, by product
7.4.5.5.2.South Korea market size and forecast, by technique
7.4.5.5.3.South Korea market size and forecast, by technique

7.4.5.6.Rest of Asia-Pacific

7.4.5.6.1.Rest of Asia-Pacific market size and forecast, by product
7.4.5.6.2.Rest of Asia-Pacific market size and forecast, by technique
7.4.5.6.3.Rest of Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key opportunities and forecast
7.5.2.Market size and forecast, by country
7.5.3.Market size and forecast, by product
7.5.4.Market size and forecast, by technique
7.5.5.Market size and forecast, by end user

7.5.5.1.Brazil

7.5.5.1.1.Brazil market size and forecast, by product
7.5.5.1.2.Brazil market size and forecast, by technique
7.5.5.1.3.Brazil market size and forecast, by end user

7.5.5.2.Saudi Arabia

7.5.5.2.1.Saudi Arabia market size and forecast, by product
7.5.5.2.2.Saudi Arabia market size and forecast, by technique
7.5.5.2.3.Saudi Arabia market size and forecast, by end user

7.5.5.3.South Africa

7.5.5.3.1.South Africa market size and forecast, by product
7.5.5.3.2.South Africa market size and forecast, by technique
7.5.5.3.3.South Africa market size and forecast, by end user

7.5.5.4.Rest of LAMEA

7.5.5.4.1.Rest of LAMEA market size and forecast, by product
7.5.5.4.2.Rest of LAMEA market size and forecast, by technique
7.5.5.4.3.Rest of LAMEA market size and forecast, by technique

LIST OF TABLES

TABLE 01.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR EQUIPMENT, BY REGION, 2020–2030($MILLION)
TABLE 03.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR REAGENTS AND KITS, BY REGION, 2020–2030($MILLION)
TABLE 04.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR OTHER, BY REGION, 2020–2030 ($MILLION)
TABLE 05.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 06.ARTIFICIAL INSEMINATION FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY REGION, 2020–2030($MILLION)
TABLE 07.ARTIFICIAL INSEMINATION FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY END USER, 2020–2030($MILLION)
TABLE 08.IN- VITRO FERTILIZATION (IVF) TECHNOLOGY FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 09.IN- VITRO FERTILIZATION (IVF) TECHNOLOGY FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 10.OTHERS FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 11.OTHERS FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 12.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY END USER, 2020–2030($MILLION)
TABLE 13.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR VETERINARY HOSPITALS, BY REGION, 2020–2028($MILLION)
TABLE 14.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR VETERINARY CLINICS, BY REGION, 2020–2030($MILLION)
TABLE 15.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR OTHERS, BY REGION, 2020–2028($MILLION)
TABLE 16.VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY REGION, 2020–2030($MILLION)
TABLE 17.NORTH AMERICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 18.NORTH AMERICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 19.NORTH AMERICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 20.NORTH AMERICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 21.U.S. VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 22.U.S. VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 23.U.S. VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 24.CANADA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 25.CANADA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 26.CANADA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 27.MEXICO VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 28.MEXICO VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 29.MEXICO VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 30.EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 31.EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 32.EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 33.EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 34.GERMANY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 35.GERMANY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 36.GERMANY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 37.FRANCE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 38.FRANCE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 39.FRANCE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 40.UK VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 41.UK VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 42.UK VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 43.ITALY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 44.ITALY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 45.ITALY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 46.SPAIN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 47.SPAIN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 48.SPAIN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 49.REST OF EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 50.REST OF EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 51.REST OF EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 52.ASIA-PACIFIC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 53.ASIA-PACIFIC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 54.ASIA-PACIFIC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 55.ASIA-PACIFIC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 56.JAPAN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 57.JAPAN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 58.JAPAN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 59.CHINA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 60.CHINA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 61.CHINA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 62.AUSTRALIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 63.AUSTRALIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 64.AUSTRALIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 65.INDIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 66.INDIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 67.INDIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 68.SOUTH KOREA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 69.SOUTH KOREA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 70.SOUTH KOREA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 71.REST OF ASIA-PACIFIC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 72.REST OF ASIA-PACIFC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 73.REST OF ASIA-PACIFC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 74.LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 75.LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 76.LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 77.LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 78.BRAZIL VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 79.BRAZIL VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 80.BRAZIL VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 81.SAUDI ARABIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 82.SAUDI ARABIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 83.SAUDI ARABIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 84.SOUTH AFRICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 85.SOUTH AFRICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 86.SOUTH AFRICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 87.REST OF LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 88.REST OF LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 89.REST OF LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)

LIST OF FIGURES

FIGURE 01.VETERINARY ARTIFICIAL REPRODUCTION MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.LOW THREAT OF NEW ENTRANTS
FIGURE 06.LOW THREAT OF SUBSTITUTION
FIGURE 07.MODERATE COMPETITIVE RIVALRY
FIGURE 08.TOP PLAYER POSITIONING, 2020
FIGURE 09.DRIVERS, RESTRAINTS, AND OPPORTUNITY
FIGURE 10.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR EQUIPMENT, BY COUNTRY, 2020–2030(%)
FIGURE 11.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR REAGENTS AND KITS, BY COUNTRY, 2020–2030(%)
FIGURE 12.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR OTHER, BY COUNTRY, 2020–2030 (%)
FIGURE 13.ARTIFICIAL INSEMINATION FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 14.IN- VITRO FERTILIZATION (IVF) TECHNOLOGY FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 15.OTHERS FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 16.VETERINARY ARTIFICIAL REPRODUCTION MARKET FOR VETERINARY HOSPITALS REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 17.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR VETERINARY CLINICS, BY COUNTRY, 2020–2030(%)
FIGURE 18.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR OTHERS, BY COUNTRY, 2020–2030(%)

 
 

The veterinary artificial reproduction market gained prominence in 2020, and is expected to witness a significant rise in the future. This is attributed to rise in incidences of chronic diseases in animals, increase in adoption of telephonic assistance to poultry owners, and farmers during COVID-19 and surge in awareness toward benefits of artificial reproduction. However, high cost of equipment impedes the market growth.

Furthermore, globally, demand for superior breed of animals is on the rise, which, in turn, propels demand for artificial reproduction procedures in animals. In addition, rise in human population along with associated advantages such as decrease in cost of housing, increase in efficiency of bull usage, safety for farmers and animals, genetic selection, and handling bull are anticipated to drive the market growth in the future.

Artificial reproduction technique helps to reduce many transmitted diseases among veterinary animals. It allows greater efficiency, in terms of genetics and allows cross-breeding of animals.

Furthermore, as per the Food and Agriculture Organization of the United Nations, approximately 50% of the global population consumes fish as food. In addition, around 580 aquatic fishes are currently being produced across the globe, which propels the need for larger production of animals, and is expected to boost demand for veterinary artificial reproduction.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of veterinary artificial reproduction marketis $1,349.4 million in 2020.

A. The forcast period for veterinary artificial reproduction marketis 2021 to 2030

A. The market value of veterinary artificial reproduction marketin 2030 is $2,229.3 million.

A. The base year is 2020 in veterinary artificial reproduction market

A. Top companies such as,Bovine Elite LLC, KRUUSE, Agtech Inc., IMV Technologies, Zoetis Inc., Neogen Corporation, National Meditek held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. By technique artificial insemination segment dominated the market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increasing consumption of animal protein and growing demand for high cattle productivity & milk yield

A. The major factor that fuels the growth of the global veterinary artificial reproduction market includes Increase in adoption veterinary artificial insemination (AI) and government support affecting animal health services influencing market growth drive the global veterinary artificial reproduction market. However, semen contamination is expected to hamper the market growth.

A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the emerging countries. This is due to the presence of a large livestock population in this region. Increasing demand for milk and animal-based protein, along with government initiatives, is propelling the market growth. Furthermore, innovation and development toward artificial reproduction are anticipated to further enhance the growth in this region in the near future.

A. Artificial reproduction is a procedure by which one manually deposits a sperm suspension, fresh or frozen-thawed, into the female reproductive tract to overcome logistical problems associated with natural mating

A. artificial insemination, in- vitro fertilization (IVF) technology and others

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Veterinary Artificial Reproduction Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers